Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma

Clinical trial NCT00704665 · COMPLETED

Trial details

NCT number: NCT00704665
Sponsor: University of Medicine and Dentistry of New Jersey
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Sclerosis

Start date: 1998-12-01
Primary completion: 2001-12-01
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.